{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:11:33Z","timestamp":1781269893967,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.03.010","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T06:16:40Z","timestamp":1489213000000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression"],"prefix":"10.1016","volume":"118","author":[{"given":"Antonio","family":"Flores-Burgess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Mill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Gago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasiel O.","family":"Borroto-Escuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Mengod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Angel","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Sant\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4613-9430","authenticated-orcid":false,"given":"Zaida","family":"D\u00edaz-Cabiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.03.010_bib1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1756-6606-4-21","article-title":"Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness","volume":"4","author":"Albert","year":"2011","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib3","doi-asserted-by":"publisher","first-page":"E8472","DOI":"10.1073\/pnas.1617824113","article-title":"Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide","volume":"113","author":"Barde","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib4","doi-asserted-by":"publisher","first-page":"10470","DOI":"10.1073\/pnas.0403802101","article-title":"Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests","volume":"101","author":"Bartfai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3940(01)02446-6","article-title":"Increased density of galanin binding sites in the dorsal raphe in a genetic rat model of depression","volume":"317","author":"Bellido","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbrc.2014.08.061","article-title":"Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex","volume":"452","author":"Borroto-Escuela","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbrc.2010.02.078","article-title":"Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization","volume":"393","author":"Borroto-Escuela","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-6147(00)01446-2","article-title":"Galanin receptor subtypes","volume":"21","author":"Branchek","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1037\/1064-1297.5.2.107","article-title":"Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression","volume":"5","author":"Detke","year":"1997","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF02246053","article-title":"Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists","volume":"119","author":"Detke","year":"1995","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00702-006-0559-6","article-title":"Receptor-receptor interactions in central cardiovascular regulation. Focus on neuropeptide\/alpha(2)-adrenoreceptor interactions in the nucleus tractus solitarius","volume":"114","author":"Diaz-Cabiale","year":"2007","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib14","first-page":"113","article-title":"Neurochemical modulation of central cardiovascular control: the integrative role of galanin","volume":"102","author":"Diaz-Cabiale","year":"2010","journal-title":"EXS"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.npep.2004.12.009","article-title":"Role of galanin and galanin(1-15) on central cardiovascular control","volume":"39","author":"Diaz-Cabiale","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.npp.1300097","article-title":"Antidepressant-like effect of different estrogenic compounds in the forced swimming test","volume":"28","author":"Estrada-Camarena","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.psyneuen.2006.05.001","article-title":"Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test","volume":"31","author":"Estrada-Camarena","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fendo.2012.00127","article-title":"On the existence and function of galanin receptor heteromers in the central nervous system","volume":"3","author":"Fuxe","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pneurobio.2009.10.012","article-title":"The discovery of central monoamine neurons gave volume transmission to the wired brain","volume":"90","author":"Fuxe","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.brainresrev.2007.11.007","article-title":"Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology","volume":"58","author":"Fuxe","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1748-1716.1988.tb08444.x","article-title":"Intraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat","volume":"133","author":"Fuxe","year":"1988","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1749-6632.1996.tb15124.x","article-title":"Galanin and 5-HT1A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain","volume":"780","author":"Hedlund","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-2999(92)90806-F","article-title":"Evidence for specific N-terminal galanin fragment binding sites in the rat brain","volume":"224","author":"Hedlund","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/sj.mp.4001920","article-title":"Serotonergic vulnerability and depression: assumptions, experimental evidence and implications","volume":"12","author":"Jans","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000054649","article-title":"Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin","volume":"73","author":"Jorgensen","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib26","doi-asserted-by":"publisher","first-page":"E1666","DOI":"10.1073\/pnas.1403649111","article-title":"Brain galanin system genes interact with life stresses in depression-related phenotypes","volume":"111","author":"Juhasz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0893-133X(02)00309-3","article-title":"Galanin is a potent in\u00a0vivo modulator of mesencephalic serotonergic neurotransmission","volume":"27","author":"Kehr","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.03.010_bib28","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00018-008-8160-9","article-title":"Galanin, galanin receptor subtypes and depression-like behaviour","volume":"65","author":"Kuteeva","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1073\/pnas.0408891102","article-title":"A\u00a0role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.neuropharm.2017.03.010_bib30","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1007\/s00429-015-1180-y","article-title":"Galanin (1\u201315) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system","volume":"221","author":"Millon","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib31","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu064","article-title":"A\u00a0role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats","volume":"18","author":"Millon","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib32","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1046\/j.1460-9568.1998.00132.x","article-title":"Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat","volume":"10","author":"Misane","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib33","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s00018-008-8153-8","article-title":"Galanin, galanin receptors and drug targets","volume":"65","author":"Mitsukawa","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0304-3940(00)01788-2","article-title":"Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine(1A) receptor mediated function in the rat","volume":"299","author":"Razani","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.euroneuro.2012.04.007","article-title":"Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatment","volume":"23","author":"Saenz del Burgo","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(24)39069-X","article-title":"Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus","volume":"294","author":"Serres","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0014-5793(83)80033-7","article-title":"Galanin - a novel biologically active peptide from porcine intestine","volume":"164","author":"Tatemoto","year":"1983","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0169-328X(97)00022-3","article-title":"Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study","volume":"46","author":"Tomiyama","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib40","doi-asserted-by":"publisher","first-page":"E4726","DOI":"10.1073\/pnas.1609198113","article-title":"Depression-like behavior in rat: involvement of galanin receptor subtype 1 in the ventral periaqueductal gray","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0014-5793(97)00695-9","article-title":"Genomic organization and functional characterization of the mouse GalR1 galanin receptor","volume":"411","author":"Wang","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2017.03.010_bib42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1749-6632.1998.tb10707.x","article-title":"Galanin: a significant role in depression?","volume":"863","author":"Weiss","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081730093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081730093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:13:37Z","timestamp":1750097617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081730093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":42,"alternative-id":["S002839081730093X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.03.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}